Randomized Controlled Trial
doi: 10.1016/j.ijcard.2011.06.112.
Epub 2011 Jul 18.
Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
- PMID: 21764467
- DOI: 10.1016/j.ijcard.2011.06.112
Item in Clipboard
Randomized Controlled Trial
Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
Int J Cardiol.
.
No abstract available
Similar articles
-
Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.Australas J Dermatol. 2011 Aug;52(3):e8-11. doi: 10.1111/j.1440-0960.2010.00660.x. Epub 2010 Jun 23. Australas J Dermatol. 2011. PMID: 21834808
-
[Adalimumab].Ann Dermatol Venereol. 2011 Dec;138(12):842-4. doi: 10.1016/j.annder.2011.10.003. Epub 2011 Nov 9. Ann Dermatol Venereol. 2011. PMID: 22137624 French. No abstract available.
-
Lack of anti-drug antibodies in patients with psoriasis well-controlled on long-term treatment with tumour necrosis factor inhibitors.Acta Derm Venereol. 2012 Jul;92(4):362-4. doi: 10.2340/00015555-1376. Acta Derm Venereol. 2012. PMID: 22864558 No abstract available.
-
Pharmacodynamics of TNF-α inhibitors in psoriasis.Expert Rev Clin Pharmacol. 2011 Jul;4(4):515-23. doi: 10.1586/ecp.11.28. Expert Rev Clin Pharmacol. 2011. PMID: 22114860 Review.
-
The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know.J Dermatolog Treat. 2013 Apr;24(2):148-52. doi: 10.3109/09546634.2011.619159. Epub 2011 Sep 30. J Dermatolog Treat. 2013. PMID: 21888569 Review.
Cited by
-
Psoriasis: Comorbidities.J Dermatol. 2021 Jun;48(6):732-740. doi: 10.1111/1346-8138.15840. Epub 2021 Mar 25. J Dermatol. 2021. PMID: 33763899 Free PMC article. Review.
-
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.Int J Mol Sci. 2017 Dec 25;19(1):58. doi: 10.3390/ijms19010058. Int J Mol Sci. 2017. PMID: 29295598 Free PMC article. Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4 PMID: 31917873 Free PMC article. Updated.
-
Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells.Oncotarget. 2016 Mar 15;7(11):11945-58. doi: 10.18632/oncotarget.7858. Oncotarget. 2016. PMID: 26943583 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5 PMID: 33871055 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
